Cann Group shares tumble after trading resumes on ASX by Steve Jones June 3, 2024June 6, 2024 Cann Group shares tumbled more than 35%, before staging a partial recovery, as it resumed trading on […]
Cann Group secures additional funding, reissues half-year results by Steve Jones May 9, 2024July 16, 2024
Optimism turns to concern as Cann Group battles financial uncertainty by Steve Jones March 7, 2024March 7, 2024
Cann Group shares suspended as auditor reports ‘insufficient evidence’ of future funding by Steve Jones March 1, 2024March 1, 2024
Australian cannabis cultivators call for industry support by Martin Lane February 22, 2024July 16, 2024
Cann Group inks deal to raise A$2m with more funds on the horizon by Steve Jones November 21, 2023April 30, 2024
Cann Group doubles revenue but ASX again seeks reassurance over finances by Steve Jones October 31, 2023April 30, 2024
Company news: Vantage Hemp; Neurotech International; MediPharm Labs/Beacon Medical; Cann Group by Martin Lane September 28, 2023April 30, 2024
Judge us on the future, not the past, says Cann Group CEO amid calls to view annual report ‘in context’ by Steve Jones August 30, 2023August 31, 2023
